With these probabilities, the urologist can discuss the different options with the patient to determine the most appropriate treatment and frequency of follow-up.
It should be noted that external validations of the EORTC tables were not always very good. The external validation in non-muscle-invasive urothelial bladder carcinoma patients by Xylinas et al. showed poor discrimination with C-statistics between 0.597 - 0.662 for the EORTC risk tables.
Still, the tables are recommended in the EAU guidelines on Non-muscle-invasive Bladder Cancer
This algorithm is provided for educational, training and information purposes. It must not be used to support medical decision making, or to provide medical or diagnostic services. Read our full Disclaimer.
{{ (typeof row === 'object') ? row.label : row }} |
{{ result.result }}
|
Evidencio B.V., Irenesingel 19, 7481 GJ Haaksbergen, The Netherlands |
|
{{ model.lot }} |
{{ model.electronicLabelWarning }} | |
|
{{ model.udi }} |
|
{{ model.representative }} |
|
Download the User manual |
|
Medical device In vitro diagnostic medical device |
{{ error }}
Please enter a password
A password has to be at least 8 characters.
A password cannot be longer then 64 characters.
Choose a password with at least one capital letter.
Choose a password with at least one special character (@$!%*#?&)
Please agree to the Terms & Conditions and the Disclaimer
Please provide your e-mail address and we'll send you a link to reset your password.
Email Address
Please enter a valid email
If an account was registered with this email address you will receive a recovery link in your mail.
Please use the reset password link in it to set your new password.
Didn't receive the email yet? Please check your spam folder, or resend the email.